Zobrazeno 1 - 10
of 16
pro vyhledávání: '"N G, Ryley"'
Publikováno v:
Asia Pacific journal of clinical nutrition. 4(1)
In-vivo 1H magnetic resonance (MR) spectra of the liver were obtained in 8 patients admitted for liver biopsy. These patients had abnormal liver function and the presumptive diagnosis of fatty liver prior to biopsy. Two patients with NIDDM were also
Publikováno v:
Cytopathology. 10:335-340
Publikováno v:
Cytopathology. 5:310-315
Autor:
Loucas Kaklamanis, Ian J. Stratford, Roland Wolf, Adrian L. Harris, Philip A. Philip, J. Carmichael, N. G. Ryley
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 29:277-283
Purpose: To determine the immunohistochemical expression of xenobiotic-metabolising enzymes (XME) in normal livers, primary hepatocellular carcinomas (hepatomas) and secondary hepatic tumors from colonic primary tumors. Methods and Materials: The exp
Autor:
Bheeshma Rajagopalan, Peter W Angus, George K. Radda, Ruth Dixon, Kenneth J. Simpson, Tim J Peters, Derek P. Jewell, N. G. Ryley
Publikováno v:
Clinical Science. 78:33-38
1. Patients with a history of alcohol abuse were studied by 31P n.m.r. spectroscopy of the liver in vivo, and the results were related to the pattern of disease assessed by standard biochemical and histological techniques. 2. The ratios of metabolite
Publikováno v:
Cytopathology : official journal of the British Society for Clinical Cytology. 10(5)
Autor:
Niall Moore, M. L. Clark, Sharon Marks, N. G. Ryley, J. J. Pointon, T. D. R. Hockaday, B. J. G. Strauss
Publikováno v:
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity. 21(4)
OBJECTIVE: To validate a variation of a well-established magnetic resonance imaging (MRI) technique to detect liver fat and use it to monitor liver fat changes after treatment with dexfenfluramine in men with non-insulin dependent diabetes mellitus (
Publikováno v:
Journal of hepatology. 23(3)
Amoxycillin/clavulanic acid (Augmentin) has been widely used as a broad spectrum antibiotic since its introduction in 1981, since which time a number of reports of adverse hepatic reaction to the drug combination have been published. This paper descr